Reprinted with permission of FFB The primary goal of the landmark study, funded by the Foundation, is to provide companies and researchers with disease-progression data and potential clinical trial endpoints to drive therapy development Columbia, MD – More than 60 leading
Foundation Fighting Blindness Clinical Research Institute Hosted Workshop for ProgStar, Largest Natural History Study for Stardardt Disease Ever Launched
